FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Date of Report (Date of earliest event reported): February 2, 2004 MEDTOX SCIENTIFIC, INC. Delaware |
1-11394 | 95-3863205 |
(Commission File Number) | (IRS Employer Identification No.) |
402 West County Road D | |
St. Paul, Minnesota | 55112 |
(Address of principal executive offices) | (Zip Code) |
(651) 636-7466 |
Item 9. Regulation FD Disclosure On February 2, 2004, Harry Alcorn, Jr., Pharm.D., resigned from the Company's Board of Directors. Dr. Alcorn cited his current work load as limiting his ability to contribute as a Director of the Company. Dr. Alcorn wished the Company well. 2 |
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
MEDTOX Scientific, Inc. | |
Date: February 2, 2004 | By: /s/ Richard J. Braun |
Name: Richard J. Braun | |
Title: Chief Executive Officer |
3 |